Until now, extensive research exploring the correlations between SLE and a wide spectrum of inflammation-related cytokines has been published—for example, the meta-analyses had reported that VEGF, IL-18, and IL-17 were elevated in patients with SLE than in healthy participants, and they could even serve as indicator of disease activity and severity (24–26). The gene discussed is IL17A; the disease is systemic lupus erythematosus.